Netherlands· NL-349f027e1e3d

Tranexaminezuur Tillomed 500 mg filmomhulde tabletten

A tranexamic acid product containing tranexaminezuur, registered in Netherlands by Tillomed Pharma GmbH. The same ATC class is registered in 15 of our 19 countries.

ATC B02AA02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tranexaminezuurAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tranexamic acid is registered in 15 of 19 countries.

Countries holding a registration under ATC B02AA02 (tranexamic acid), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search tranexamic acid products by name

Tranexamic acid · ATC B02AA02

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tranexamic acid costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $1.69 in Italy to $34.44 in Switzerland — a ×20 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Tranexamic acid · price per daily dose (2 g)

USD · FX 28 Sept 2026

CH Switzerland$34.44
IT Italy$1.69

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TRANEXAMINEZUUR
Manufacturer: Tillomed Pharma GmbH
Country: Netherlands (NL)
ATC code: B02AA02
ATC class: Tranexamic acid
Defined daily dose: 2 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
116279

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

45 interactions on record for tranexamic acid.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tranexamic acid against other medicines How interaction checks work

Tranexamic acid · interactions on record

45 records

36 severe
8 moderate
1 minor

Most severe, free to view

Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
EstradiolD11AX34severe
IUP aus Plastik mit GestagenG02BA03severe
Levonorgestrel and ethinylestradiolG03AA07severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tranexamic acid in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tranexamic acid products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Cyklokapron, Tranexamsäure Baxter
Belgium · Acide Tranexamique Kabi, Cyklokapron
Bulgaria · Медокапрон, Т-Капрон
Cyprus · Azeptil, Medsamic
Czechia · Exacyl, Tranexamic Acid Accord
Germany · Cyklokapron, Cyklokapron-Injektionslösung
Denmark · Cyklokapron, Cyklonova
Estonia · Cyklokapron, Medsamic
Spain · Ácido Tranexámico Baxter, Ácido Tranexámico Viatris
Finland · Caprilon, Cyklokapron
France · Acide Tranexamique Accord, Acide Tranexamique Aguettant
United Kingdom (Northern Ireland) · Cyklo-F, Cyklokapron
Greece · Tranexamic Acid /Kabi, Tranexamic Acid Baxter
Croatia · Medsamic, Trenolk
Hungary · Exacyl, Nimra
Ireland · Cyklokapron, Tranexamic Acid Accord Healthcare Ireland
Iceland · Cyklokapron, Tranexamsyre Pfizer
Italy · Acido Tranexamico Adamed, Acido Tranexamico Aurobindo
Lithuania · Haixa, Tranexamic Acid Baxter
Luxembourg · Exacyl, Tranexamsäure Dr. Eberth
Latvia · Cyklokapron, Haixa
Malta · Azeptil, Medsamic
Norway · Cyklokapron, Pilexam
Poland · Deporium, Deporium Comfort
Portugal · Ácido Tranexâmico A.Forall, Ácido Tranexâmico Accord
Romania · Acid Tranexamic Kabi, Medsamic
Sweden · Cyklo-F, Cyklokapron
Slovenia · Medsamic, Trenolk
Slovakia · Medsamic, Tranexamic Acid Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dc71eb9a-63eb-46d8-b3ba-a10598d4ec55
GET /v1/drugs/dc71eb9a-63eb-46d8-b3ba-a10598d4ec55?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116279_smpc.pdf",
  "strength": null,
  "atc_label": "Tranexamic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116279",
  "excipients": [
    "CASTOROLIE, GEHYDROGENEERD",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "HYPROMELLOSE (E 464)",
    "MACROGOL",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "NATRIUMLAURILSULFAAT",
    "POVIDON K 30 (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "TRANEXAMINEZUUR"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116279.pdf",
  "authorised_at": "2016/02/01",
  "procedure_number": "DE/H/5754/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "116279",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about tranexamic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console